2m 2m 2m 2m 2m 2m 2m
MONOPAR THERAPE (MNPR)
NASDAQ
$84.00+$2.23 (+2.73%)
Price as of Jun 23, 2026 7:42 PM EDT- $460.0MMarket Cap
- 145.56%1-Year Change
- BiotechnologyIndustry
MONOPAR THERAPE (MNPR)
$84.00+$2.23 (+2.73%)
MNPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $81.77 | ||
Change | +$13.11 (+19.09%) | ||
Open | $68.21 | ||
High | $83.56 | ||
Low | $68.21 | ||
Previous Close | $68.66 | ||
Volume | 278,172 | ||
30-Day Average Volume | 134,157 | ||
1-Week Change | 31.15% | ||
1-Month Change | 29.55% | ||
1-Year Change | 145.56% | ||
3-Year Change | 1,779.77% | ||
5-Year Change | 172.11% | ||
Fundamentals | |||
Shares Outstanding | 6.7M | ||
Total Assets | $138.0M | ||
Market Cap | $460.0M | ||
Enterprise Value | $407.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$3.9M | ||
Free Cash Flow | -$3.5M | ||
EBIT | -$3.9M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $135.3M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -105 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -149 | ||
PEG | -6 | ||
Price/Free Cash Flow | -132 | ||
Price/Operating Cash Flow | -132 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 08/13/2024 | ||
Earnings & Revenue